-9%
4X Tested - ISO 17025
Growth Hormone Secretagogue

CJC-1295 no/DAC

Certificate of Analysis

CJC-1295 (without DAC) is a growth hormone-releasing hormone (GHRH) analog studied for its role in stimulating pulsatile GH release, supporting research into recovery, body composition, and tissue repair.

BUNDLE & SAVE
2-Day Shipping

Free Shipping
over $200

Free shipment
protection

Secure Checkout
256-bit SSL


Description

What is CJC-1295 no/DAC?

CJC-1295 (without DAC), also known as Modified GRF (1-29) or mod GRF (1-29), is a synthetic 29-amino-acid analog of the first 29 amino acids of growth hormone-releasing hormone (GHRH). The peptide contains four amino acid modifications that protect it from enzymatic degradation while preserving its biological activity.

The “without DAC” designation distinguishes it from CJC-1295 with DAC (Drug Affinity Complex), a related compound modified with a lysine linker that binds to serum albumin to extend its half-life to days. Without DAC, the peptide has a short half-life (approximately 30 minutes), producing brief, pulsatile GH release that more closely mirrors the body’s natural endogenous rhythm.

In preclinical and early clinical research, CJC-1295 (without DAC) has been studied for its ability to stimulate pulsatile growth hormone release through the GHRH receptor, support increases in IGF-1 levels, and contribute to research on recovery, sleep architecture, and body composition. It is frequently studied in combination with the ghrelin mimetic Ipamorelin, which acts on a different receptor to amplify GH release.


Research Applications

Areas of Investigation
GH Signaling

Pulsatile GH Release

Studied for its ability to stimulate brief, pulsatile growth hormone release through the GHRH receptor, more closely mimicking the body's natural endogenous rhythm than longer-acting analogs.
Healing

Recovery & Tissue Repair

Investigated in preclinical models for its role in supporting cellular repair, muscle recovery, and connective tissue regeneration following injury or strain.
Endocrine

IGF-1 Modulation

Research has documented increases in insulin-like growth factor 1 (IGF-1) following GHRH analog administration, a downstream marker of growth hormone activity.
Composition

Body Composition & Sleep

Studied for its effects on lean mass, adipose tissue distribution, and slow-wave sleep architecture in research populations exploring age-related changes in GH signaling.

Compound Profile

Technical specifications
What is CJC-1295 no/DAC?

Molecular Profile


Sequence
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
Molecular Formula
C₁₅₂H₂₅₂N₄₄O₄₂
Molecular Weight
3367.97 g/mol
Appearance
White lyophilized powder

Form

Lyophilized (freeze-dried)
Handling & Shelf Life Guidelines

Storage & Stability


Storage (Pre-Reconstitution)

Store below -18°C, desiccated, away from light and moisture.
Storage (Post-Reconstitution)
Refrigerate at 2–8°C. For longer storage, aliquot and store below -18°C. Avoid freeze-thaw cycles.
Shelf Life
24 months from date of manufacture when stored as directed
Sensitivity Notes
Sensitive to heat, light, and moisture. Reconstituted peptide is most stable when refrigerated and protected from oxidation.
Compliance & Clinical Overview

Regulatory & Research Status


FDA Status
Not approved as a pharmaceutical drug. Not regulated as a dietary supplement. Sold strictly as a research chemical.
WADA Classification
Prohibited at all times (in and out of competition) under the World Anti-Doping Agency's S2 category: Peptide Hormones, Growth Factors, Related Substances and Mimetics.
Clinical Trial Status
Preclinical and early clinical research on GHRH analog pharmacokinetics, GH/IGF-1 stimulation, and body composition effects. Most published trial data comes from the with-DAC variant.
Published Studies
Preclinical and early clinical research on GHRH analog pharmacokinetics, GH/IGF-1 stimulation, and body composition effects. Most published trial data comes from the with-DAC variant.
Research Disclaimer
For laboratory and research purposes only. Not intended for human consumption.

COA's (Certificate of Analysis)

Third Party Tested by Freedom Diagnostics
98.70%
Purity
Variant
CJC-1295 NO/DAC
Lot #
GL-2609-006
Labelled
5mg
Actual
5.13mg
Tested
9/14/2026
View COA
(opens in a new tab)
99.78%
Purity
Variant
CJC-1295 NO/DAC
Lot #
GLZ-CJC-1295NO/DAC-10MG-A
Labelled
5mg
Actual
5.45mg
Tested
5/11/206
View COA
(opens in a new tab)

Frequently Asked Questions

Common questions about CJC-1295 no/DAC research